Literature DB >> 29206475

Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection.

Steven A Cowman1,2, Joseph Jacob1,3, David M Hansell1,3, Peter Kelleher1,2, Robert Wilson1,2, William O C Cookson1, Miriam F Moffatt1, Michael R Loebinger1,2.   

Abstract

The factors predisposing toward the development of pulmonary nontuberculous mycobacterial (pNTM) disease and influencing disease progression remain unclear. Impaired immune responses have been reported in individuals with pNTM disease, but data are limited and inconsistent. In this study, we sought to use gene expression profiling to examine the host response to pNTM disease. Microarray analysis of whole-blood gene expression was performed on 25 subjects with pNTM disease and 27 uninfected control subjects with respiratory disease. Gene expression results were compared with phenotypic variables and survival data. Compared with uninfected control subjects, pNTM disease was associated with downregulation of 213 transcripts enriched for terms related to T cell signaling, including IFNG. Reduced IFNG expression was associated with more severe computed tomography changes and impaired lung function. Mortality was associated with the expression of transcripts related to the innate immune response and inflammation, whereas transcripts related to T and B cell function were associated with improved survival. These findings suggest that pNTM disease is associated with an aberrant immune response, which may reflect an underlying propensity to infection or result from NTM infection itself. There were important differences in the immune response associated with survival and mortality in pNTM disease.

Entities:  

Keywords:  gene expression profiling; interferon-γ; nontuberculous mycobacteria

Mesh:

Substances:

Year:  2018        PMID: 29206475      PMCID: PMC5894497          DOI: 10.1165/rcmb.2017-0230OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  60 in total

Review 1.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

2.  Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection.

Authors:  Y Yamazaki; K Kubo; A Takamizawa; H Yamamoto; T Honda; S Sone
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

3.  Regulation of interferon-gamma gene expression by nuclear factor of activated T cells.

Authors:  A Kiani; F J García-Cózar; I Habermann; S Laforsch; T Aebischer; G Ehninger; A Rao
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

4.  Receptor for advanced glycation end products is protective during murine tuberculosis.

Authors:  Marieke A D van Zoelen; Catharina W Wieland; Gerritje J W van der Windt; Sandrine Florquin; Peter P Nawroth; Angelika Bierhaus; Tom van der Poll
Journal:  Mol Immunol       Date:  2012-06-13       Impact factor: 4.407

5.  Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.

Authors:  Carl G Feng; Charles A Scanga; Carmen M Collazo-Custodio; Allen W Cheever; Sara Hieny; Patricia Caspar; Alan Sher
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

6.  Decreased cytokine production in patients with nontuberculous mycobacterial lung disease.

Authors:  Yong Soo Kwon; Eun Joo Kim; Shin-Hye Lee; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Won-Jung Koh
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

Review 7.  The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.

Authors:  Jan M Ehrchen; Cord Sunderkötter; Dirk Foell; Thomas Vogl; Johannes Roth
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

8.  Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease.

Authors:  Y J Ryu; E J Kim; S-H Lee; S Y Kim; G Y Suh; M P Chung; H Kim; O J Kwon; W-J Koh
Journal:  Eur Respir J       Date:  2007-06-13       Impact factor: 16.671

9.  Mycobacterium abscessus activates the NLRP3 inflammasome via Dectin-1-Syk and p62/SQSTM1.

Authors:  Hye-Mi Lee; Jae-Min Yuk; Ki-Hye Kim; Jichan Jang; Gun Kang; Jin Bong Park; Ji-Woong Son; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2011-08-30       Impact factor: 5.126

10.  Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.

Authors:  Mina Gochi; Noboru Takayanagi; Tetsu Kanauchi; Takashi Ishiguro; Tsutomu Yanagisawa; Yutaka Sugita
Journal:  BMJ Open       Date:  2015-08-05       Impact factor: 2.692

View more
  6 in total

1.  Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Vincent X Liu; Kevin L Winthrop; Yun Lu; Husham Sharifi; Hekmat U Nasiri; Stephen J Ruoss
Journal:  Ann Am Thorac Soc       Date:  2018-10

2.  Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIV.

Authors:  Ethan D Valinetz; Daniel Matemo; Jill K Gersh; Lara L Joudeh; Simon C Mendelsohn; Thomas J Scriba; Mark Hatherill; John Kinuthia; Anna Wald; Gerard A Cangelosi; Ruanne V Barnabas; Thomas R Hawn; David J Horne
Journal:  AIDS       Date:  2022-05-25       Impact factor: 4.632

Review 3.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

4.  T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease.

Authors:  Cecilia S Lindestam Arlehamn; Basilin Benson; Rebecca Kuan; Kimberly A Dill-McFarland; Glenna J Peterson; Sinu Paul; Felicia K Nguyen; Robert H Gilman; Mayuko Saito; Randy Taplitz; Matthew Arentz; Christopher H Goss; Moira L Aitken; David J Horne; Javeed A Shah; Alessandro Sette; Thomas R Hawn
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

5.  Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.

Authors:  Joseph Jacob; Arlette Odink; Anne Laure Brun; Claudio Macaluso; Angelo de Lauretis; Maria Kokosi; Anand Devaraj; Sujal Desai; Elisabetta Renzoni; Athol U Wells
Journal:  Respir Med       Date:  2018-03-30       Impact factor: 3.415

6.  Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent.

Authors:  Mary A De Groote; Thale C Jarvis; Christina Wong; James Graham; Teresa Hoang; Casey L Young; Wendy Ribble; Joshua Day; Wei Li; Mary Jackson; Mercedes Gonzalez-Juarrero; Xicheng Sun; Urs A Ochsner
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.